Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
LTZ Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
Eli Lilly and Company
Verismo Therapeutics
GenomeFrontier Therapeutics TW Co., Ltd.
Ipsen
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Ipsen
Cyteir Therapeutics, Inc.
Atara Biotherapeutics
Gilead Sciences
Novartis
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
SymBio Pharmaceuticals
Novartis